603367 辰欣藥業
按盤價 
23.270 +2.120 (+10.024%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.808 | 8.716 | 9.428 | 6.738 | 6.781 |
| 總資產報酬率 ROA (%) | 3.020 | 6.835 | 7.367 | 5.311 | 5.334 |
| 投入資產回報率 ROIC (%) | 3.610 | 8.222 | 8.878 | 6.399 | 6.331 | 邊際利潤分析 |
| 銷售毛利率 (%) | 56.162 | 56.573 | 58.788 | 55.995 | 55.463 |
| 營業利潤率 (%) | 14.757 | 14.367 | 13.280 | 8.966 | 8.841 |
| 息稅前利潤/營業總收入 (%) | 14.049 | 13.645 | 12.598 | 8.320 | 8.646 |
| 淨利潤/營業總收入 (%) | 13.294 | 12.933 | 11.775 | 8.664 | 8.827 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.082 | 86.511 | 99.968 | 95.161 | 73.120 |
| 價值變動淨收益/利潤總額(%) | 21.651 | 12.650 | 5.663 | 4.249 | 19.761 |
| 營業外收支淨額/利潤總額(%) | -0.111 | 0.647 | 0.550 | 0.439 | 0.509 | 償債能力分析 |
| 流動比率 (X) | 3.649 | 3.333 | 3.628 | 3.701 | 3.400 |
| 速動比率 (X) | 3.095 | 2.788 | 3.111 | 3.249 | 2.912 |
| 資產負債率 (%) | 19.636 | 20.743 | 21.415 | 21.412 | 20.556 |
| 帶息債務/全部投入資本 (%) | 3.442 | 4.458 | 4.567 | 4.527 | 2.434 |
| 股東權益/帶息債務 (%) | 2,764.258 | 2,118.093 | 2,063.545 | 2,078.695 | 3,938.352 |
| 股東權益/負債合計 (%) | 406.578 | 379.711 | 364.479 | 365.406 | 386.412 |
| 利息保障倍數 (X) | -20.306 | -16.725 | -16.697 | -12.136 | -36.002 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 68.321 | 61.932 | 58.758 | 54.201 | 47.925 |
| 存貨周轉天數 (天) | 187.113 | 158.092 | 126.130 | 118.211 | 124.666 |
| 備註： | 即時報價更新時間為 17/10/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
